4
Changes in Ownership
Vistagen Therapeutics, Inc. Filed Acc 0001415889-18-001321
Options or other derivatives
- PRES./CHIEF SCIENTIFIC OFFICER acquired 346,250 shares (grant or award)
- PRES./CHIEF SCIENTIFIC OFFICER returned 346,250 shares (to the company)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| SNODGRASS H. RALPH PRES./CHIEF SCIENTIFIC OFFICER | 2018-08-29 | Returned to the company · Stock Option (Right to Buy) | −2,500 | 0 | D | ||
| SNODGRASS H. RALPH PRES./CHIEF SCIENTIFIC OFFICER | 2018-08-29 | Grant or award · Stock Option (Right to Buy) | +2,500 | 2,500 | D | ||
| SNODGRASS H. RALPH PRES./CHIEF SCIENTIFIC OFFICER | 2018-08-29 | Returned to the company · Stock Option (Right to Buy) | −1,250 | 0 | D | ||
| SNODGRASS H. RALPH PRES./CHIEF SCIENTIFIC OFFICER | 2018-08-29 | Grant or award · Stock Option (Right to Buy) | +1,250 | 1,250 | D | ||
| SNODGRASS H. RALPH PRES./CHIEF SCIENTIFIC OFFICER | 2018-08-29 | Returned to the company · Stock Option (Right to Buy) | −12,500 | 0 | D | ||
| SNODGRASS H. RALPH PRES./CHIEF SCIENTIFIC OFFICER | 2018-08-29 | Grant or award · Stock Option (Right to Buy) | +12,500 | 12,500 | D | ||
| SNODGRASS H. RALPH PRES./CHIEF SCIENTIFIC OFFICER | 2018-08-29 | Returned to the company · Stock Option (Right to Buy) | −125,000 | 0 | D | ||
| SNODGRASS H. RALPH PRES./CHIEF SCIENTIFIC OFFICER | 2018-08-29 | Grant or award · Stock Option (Right to Buy) | +125,000 | 125,000 | D | ||
| SNODGRASS H. RALPH PRES./CHIEF SCIENTIFIC OFFICER | 2018-08-29 | Returned to the company · Stock Option (Right to Buy) | −80,000 | 0 | D | ||
| SNODGRASS H. RALPH PRES./CHIEF SCIENTIFIC OFFICER | 2018-08-29 | Grant or award · Stock Option (Right to Buy) | +80,000 | 80,000 | D | ||
| SNODGRASS H. RALPH PRES./CHIEF SCIENTIFIC OFFICER | 2018-08-29 | Returned to the company · Stock Option (Right to Buy) | −125,000 | 0 | D | ||
| SNODGRASS H. RALPH PRES./CHIEF SCIENTIFIC OFFICER | 2018-08-29 | Grant or award · Stock Option (Right to Buy) | +125,000 | 125,000 | D | ||
Loading xslF345X03/form4-08312018_020835.xml…